ArticleJournal of clinical hypertension (Greenwich, Conn.)2026
Predictive Value of D-Dimer to Albumin Ratio for Outcome in Acute Type A Aortic Dissection Patients.
Article in Journal of clinical hypertension (Greenwich, Conn.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Preoperative risk assessment and identification of potential biomarkers may optimize prognostic outcomes in patients with aortic dissection patients. The relationship between the D-dimer to albumin ratio (DAR), an emerging biomarker that has recently attracted increasing attention, and postoperative outcomes in patients with acute type A aortic dissection (AAAD) remains unclear. Therefore, this study seeks to validate the correlation between DAR and adverse outcomes after surgery in this population and to provide a reliable reference for postoperative risk assessment in clinical AAAD. Patients with AAAD treated at Fujian Medical University Union Hospital between July 2013 and December 2021 were admitted in this cross-sectional retrospective study. To examine the link between DAR and poor prognosis in AAAD patients, logistic regression analysis was performed. The predictive capacity of the DAR was assessed through the receiver operating characteristic curve analysis. The entirety of 619 individuals were ultimately included, with 106 (17.12%) patients died within 30 days of surgery. The group with the highest DAR levels had the highest number of adverse outcomes, including postoperative mortality, adverse cardiovascular, and cerebrovascular events. DAR was independently associated with postoperative mortality within 30 days in patients with AAAD, as determined by multivariate regression analysis (OR: 3.604, 95% CI: 1.495-8.685, p = 0.004). DAR shows good predictive performance for postoperative mortality within 30 days in AAAD patients (AUC: 0.710, 95% CI: 0.656-0.764, P < 0.001). These findings suggest that DAR is significantly associated with 30-day postoperative mortality in patients with AAAD and has good predictive value.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.